InvestSMART

Starpharma Holdings Limited (ASX:SPL)

ALERT: Price-sensitive ASX Announcement for SPL
Current share price for SPL : $0.810 0.015 (1.89%)+
Announcement
Release
11 Aug 2026 9:49AM
Price at Release
$0.795
Full Release
download
Summary
Starpharma Holdings Limited announced the successful completion of a $32 million Entitlement Offer, with a high take-up rate of approximately 99% among existing shareholders. The offer involved a 1 for 7.5 renounceable pro rata offer of new shares, resulting in the issuance of 56,126,514 new shares, which will rank equally with existing shares. The funds raised will be used to support clinical trials and further develop oncology assets. Starpharma continues to focus on advancing its dendrimer technology for medical applications, aiming to build a high-value pipeline of targeted oncology assets.
Key Points
  • Starpharma Holdings Limited successfully completed a $32 million Entitlement Offer.
  • The Entitlement Offer was a 1 for 7.5 renounceable pro rata offer of new fully paid ordinary shares.
  • The offer received a take-up rate of approximately 99% with strong support from existing shareholders.
  • 56,126,514 new shares were issued and are expected to rank equally with existing shares.
  • Funds raised will support clinical trials and advance oncology assets.
  • Starpharma focuses on dendrimer technology for medical applications.
  • The company aims to build a pipeline of targeted oncology assets.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.